Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.42 - $0.72 $100,453 - $172,206
239,176 New
239,176 $150,000
Q3 2023

Nov 13, 2024

BUY
$0.6 - $1.53 $143,505 - $365,939
239,176 New
239,176 $143,000
Q3 2023

Nov 13, 2023

SELL
$0.6 - $1.53 $296,722 - $756,641
-494,537 Closed
0 $0
Q2 2023

Aug 14, 2024

BUY
$1.05 - $1.63 $251,134 - $389,856
239,176 New
239,176 $270,000
Q2 2023

Aug 14, 2023

SELL
$1.05 - $1.63 $2.26 Million - $3.51 Million
-2,153,506 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$1.2 - $2.73 $287,011 - $652,950
239,176 New
239,176 $322,000
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $408,990 - $863,425
239,176 New
239,176 $444,000
Q3 2022

Nov 13, 2023

BUY
$1.9 - $8.63 $939,620 - $4.27 Million
494,537 New
494,537 $1.22 Million
Q2 2022

Aug 14, 2023

BUY
$2.13 - $9.01 $4.59 Million - $19.4 Million
2,153,506 New
2,153,506 $5.25 Million
Q1 2022

May 12, 2023

BUY
$6.28 - $15.59 $12 Million - $29.8 Million
1,914,330 Added 800.39%
2,153,506 $17.2 Million
Q1 2022

May 09, 2022

SELL
$6.28 - $15.59 $13.1 Million - $32.5 Million
-2,081,840 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$14.7 - $28.67 $30.6 Million - $59.7 Million
2,081,840 New
2,081,840 $31.8 Million
Q3 2021

Nov 14, 2022

BUY
$24.31 - $33.6 $46.9 Million - $64.8 Million
1,929,576 New
1,929,576 $54.9 Million
Q3 2021

Nov 05, 2021

SELL
$24.31 - $33.6 $41.4 Million - $57.3 Million
-1,704,673 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$26.09 - $40.4 $44.5 Million - $68.9 Million
1,704,673 New
1,704,673 $57.5 Million
Q2 2021

Aug 10, 2021

SELL
$26.09 - $40.4 $36.9 Million - $57.2 Million
-1,415,518 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$33.06 - $56.93 $46.8 Million - $80.6 Million
1,415,518 New
1,415,518 $54.1 Million
Q1 2021

May 07, 2021

SELL
$33.06 - $56.93 $47.8 Million - $82.4 Million
-1,446,818 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$39.09 - $57.4 $56.6 Million - $83 Million
1,446,818 New
1,446,818 $60.5 Million
Q4 2020

Feb 10, 2021

SELL
$39.09 - $57.4 $60.3 Million - $88.6 Million
-1,542,984 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$28.43 - $44.67 $43.9 Million - $68.9 Million
1,542,984 New
1,542,984 $66.9 Million
Q3 2020

Nov 10, 2020

SELL
$28.43 - $44.67 $49.9 Million - $78.5 Million
-1,756,434 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$11.71 - $30.29 $20.6 Million - $53.2 Million
1,756,434 New
1,756,434 $53.2 Million
Q2 2020

Aug 07, 2020

SELL
$11.71 - $30.29 $15.1 Million - $39 Million
-1,287,785 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$7.64 - $27.5 $9.84 Million - $35.4 Million
1,287,785 New
1,287,785 $17.6 Million
Q1 2020

May 08, 2020

SELL
$7.64 - $27.5 $9.27 Million - $33.4 Million
-1,213,711 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$15.02 - $20.57 $18.2 Million - $25 Million
1,213,711 New
1,213,711 $19.6 Million
Q4 2019

Feb 12, 2020

SELL
$15.02 - $20.57 $13.4 Million - $18.4 Million
-893,211 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$18.85 - $27.5 $16.8 Million - $24.6 Million
893,211 New
893,211 $17.2 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.